Dynavax Technologies Corp.

DVAX

Market Cap$1.46B

Close$

Compare Dynavax Technologies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Dynavax Technologies Corp.	-228.8	0%	-1%	11.7	0.4
Market Avg	58.9	1.29%	29%	-	1
Healthcare Avg	66.3	1.31%	15%	-	0.9

$18.52

Current Fair Value

58.6% upside

Undervalued by 58.6% based on the discounted cash flow analysis.

Share Statistics

Market cap	$1.46 Billion
Enterprise Value	$942.13 Million
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-0.05
Beta	0.0
Outstanding Shares	130,862,916
Avg 30 Day Volume	2,091,791

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-228.79
PEG	229.53
Price to Sales	11.68
Price to Book Ratio	2.92
Enterprise Value to Revenue	4.06
Enterprise Value to EBIT	-24.77
Enterprise Value to Net Income	-148
Total Debt to Enterprise	0.24
Debt to Equity	0.36

Revenue Sources

No data

ESG Score

No data

About Dynavax Technologies Corp.

CEO: Ryan Spencer